Korea Investment Corp’s Abiomed Inc ABMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-73,499
Closed -$18.1M 776
2022
Q3
$18.1M Buy
73,499
+58,110
+378% +$15.7M 0.06% 318
2022
Q2
$3.81M Buy
15,389
+1,189
+8% +$321K 0.01% 609
2022
Q1
$4.7M Buy
14,200
+4,000
+39% +$1.23M 0.01% 585
2021
Q4
$3.66M Buy
10,200
+2,000
+24% +$676K 0.01% 574
2021
Q3
$2.67M Sell
8,200
-1,600
-16% -$542K 0.01% 633
2021
Q2
$3.06M Buy
9,800
+300
+3% +$92K 0.01% 630
2021
Q1
$3.03M Sell
9,500
-3,000
-24% -$960K 0.01% 602
2020
Q4
$4.05M Buy
12,500
+600
+5% +$166K 0.01% 552
2020
Q3
$3.3M Sell
11,900
-200
-2% -$57.6K 0.01% 514
2020
Q2
$2.92M Buy
12,100
+700
+6% +$141K 0.01% 527
2020
Q1
$1.66M Buy
+11,400
New +$1.89M 0.01% 594
2019
Q4
Sell
-300
Closed -$53K 675
2019
Q3
$53K Sell
300
-15,039
-98% -$3.25M ﹤0.01% 642
2019
Q2
$4M Sell
15,339
-22,000
-59% -$5.84M 0.02% 475
2019
Q1
$10.7M Buy
37,339
+5,010
+15% +$1.67M 0.05% 347
2018
Q4
$10.5M Buy
32,329
+4,600
+17% +$1.6M 0.06% 318
2018
Q3
$12.5M Buy
27,729
+7,990
+40% +$3.15M 0.06% 306
2018
Q2
$8.07M Buy
+19,739
New +$7.15M 0.04% 381

Other funds holding ABMD

Korea Investment Corp's ABMD Position: Q4 2022 in Review

Korea Investment Corp sold out of Abiomed Inc (ABMD) in Q4 2022, closing a stake of 73,499 shares — an estimated $18.1M sold.

Korea Investment Corp first reported a position in ABMD in Q2 2018 and held it in 17 quarters. The position peaked at $18.1M in Q3 2022. 8 funds tracked by Wall St. Rank hold ABMD as of Q4 2022.

  • Korea Investment Corp reported no remaining Abiomed Inc position as of Q4 2022 after selling out during the quarter.
  • Korea Investment Corp sold 73,499 Abiomed Inc shares in Q4 2022, an estimated $18.1M.
  • Korea Investment Corp first reported a position in Abiomed Inc in Q2 2018 and held it in 17 quarters.
  • Korea Investment Corp's Abiomed Inc position peaked at $18.1M in Q3 2022.
  • 8 funds tracked by Wall St. Rank held Abiomed Inc as of Q4 2022.

Based on Korea Investment Corp's 13F filing for Q4 2022, filed 13 Feb 2023.